Original article
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Muhammad Kashif Amina,b, Moazzam Shahzadb,c, Abat Khana,b, Valiko Begiashvilia,b, Ushna Khana,b, Matthew McGuirka,b, Shaun DeJarnettea, Sibgha Gull Chaudharya,b, Iqra Anwara,b, Nausheen Ahmeda,b, Al-Ola Abdallaha,b, Sunil H. Abhyankara,b, Joseph P. McGuirka,b, Anurag K. Singha,b, Muhammad Umair Mushtaqa,b,
Autor para correspondência
mmushtaq@kumc.edu
Corresponding author at: Division of Hematologic Malignancies and Cellular Therapeutics, University of KS Medical Center, 2330 Shawnee Mission Parkway, Suite 210, MS 5003, Westwood, KS 66205, USA.
Corresponding author at: Division of Hematologic Malignancies and Cellular Therapeutics, University of KS Medical Center, 2330 Shawnee Mission Parkway, Suite 210, MS 5003, Westwood, KS 66205, USA.
